Clinical trials
Active, not recruiting Alzheimer Disease trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
149 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2011 | 2 |
| 2012 | 3 |
| 2016 | 5 |
| 2017 | 2 |
| 2018 | 5 |
| 2019 | 6 |
| 2020 | 8 |
| 2021 | 19 |
| 2022 | 19 |
| 2023 | 28 |
| 2024 | 27 |
| 2025 | 21 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 149 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Washington University School of Medicine | 7 |
| Eli Lilly and Company | 6 |
| Hoffmann-La Roche | 5 |
| Centre for Addiction and Mental Health | 3 |
| Eisai Inc. | 3 |
| Mayo Clinic | 3 |
| NYU Langone Health | 3 |
| Stanford University | 3 |
| Anne Murray | 2 |
| Barcelonabeta Brain Research Center, Pasqual Maragall Foundation | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alzheimer Disease | 149 |
| Cognitive Dysfunction | 53 |
| Dementia | 50 |
| Neurodegenerative Diseases | 9 |
| Brain Diseases | 5 |
| Dementia, Vascular | 5 |
| Memory Disorders | 5 |
| Neurocognitive Disorders | 5 |
| Parkinson Disease | 5 |
| Psychomotor Agitation | 5 |
Trials
Showing 26 to 50 of 149. Each trial links to its page on Pharma Observatory.
49 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.